Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
65
AHR Quote, Financials, Valuation and Earnings
Last price:
$51.92
Seasonality move
:
13.77%
Day range:
$51.72 - $52.68
52-week range:
$26.48 - $53.10
Dividend yield:
1.93%
P/E ratio:
368.82x
P/S ratio:
3.78x
P/B ratio:
3.45x
Volume:
1.9M
Avg. volume:
3.1M
1-year change:
86.33%
Market cap:
$9.3B
Revenue:
$2.1B
EPS (TTM):
$0.14
Analysts' Opinion
-
Consensus RatingAmerican Healthcare REIT, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $56.08, American Healthcare REIT, Inc. has an estimated upside of 7.99% from its current price of $51.93.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $52.00 representing 100% downside risk from its current price of $51.93.
Fair Value
-
According to the consensus of 8 analysts, American Healthcare REIT, Inc. has 7.99% upside to fair value with a price target of $56.08 per share.
AHR vs. S&P 500
-
Over the past 5 trading days, American Healthcare REIT, Inc. has underperformed the S&P 500 by -0.62% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
American Healthcare REIT, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
American Healthcare REIT, Inc. has grown year-over-year revenues for 11 quarters straight. In the most recent quarter American Healthcare REIT, Inc. reported revenues of $573M.
Earnings Growth
-
American Healthcare REIT, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter American Healthcare REIT, Inc. reported earnings per share of $0.33.
Enterprise value:
10.8B
EV / Invested capital:
--
Price / LTM sales:
3.78x
EV / EBIT:
61.36x
EV / Revenue:
4.90x
PEG ratio (5yr expected):
-0.25x
EV / Free cash flow:
57.24x
Price / Operating cash flow:
44.12x
Enterprise value / EBITDA:
30.40x
Gross Profit (TTM):
$228.4M
Return On Assets:
0.6%
Net Income Margin (TTM):
1.25%
Return On Equity:
1.14%
Return On Invested Capital:
0.65%
Operating Margin:
7.45%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.9B | $2B | $2.2B | $516.5M | $573M | |
| Gross Profit | -$134.2M | $136.4M | $228.4M | $41.9M | $56.6M | |
| Operating Income | -$173.9M | $78.3M | $176.1M | $21.1M | $42.7M | |
| EBITDA | $292.5M | $254.5M | $355.5M | $65.3M | $92M | |
| Diluted EPS | -- | -$0.05 | $0.14 | -$0.03 | $0.33 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $34.4M | $306.2M | $169.5M | $370.6M | $421.7M | |
| Total Assets | $1.1B | $4.8B | $4.6B | $4.7B | $4.8B | |
| Current Liabilities | $511.3M | $249.3M | $233.9M | $304.3M | $304.6M | |
| Total Liabilities | $546M | $3B | $3.1B | $2.4B | $2.1B | |
| Total Equity | $517.9M | $1.7B | $1.5B | $2.3B | $2.7B | |
| Total Debt | $518.6M | $2.8B | $2.8B | $2.1B | $1.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $107.1M | $142.3M | $298.9M | $63.1M | $107.2M | |
| Cash From Investing | $3.6M | -$409.2M | -$286.9M | -$288.6M | -$278.6M | |
| Cash From Financing | -$153M | $295.2M | $55.7M | $244.5M | $185.8M | |
| Free Cash Flow | $12.5M | $54.7M | $188.8M | $39.2M | $74.8M | |
AHR
Sector
Market Cap
$9.3B
$938.7M
Price % of 52-Week High
97.8%
89.86%
Dividend Yield
1.93%
2.26%
Shareholder Yield
-4.38%
3.36%
1-Year Price Total Return
86.33%
--
Beta (5-Year)
--
0.634
Dividend yield:
1.93%
Annualized payout:
$0.00
Payout ratio:
75.9%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$51.86
200-day SMA
Buy
Level
$42.52
Bollinger Bands (100)
Buy
Level
43.84 - 50.02
Chaikin Money Flow
Buy
Level
85.1M
20-day SMA
Buy
Level
$49.12
Relative Strength Index (RSI14)
Buy
Level
65.52
ADX Line
Buy
Level
25.47
Williams %R
Sell
Level
-16.6192
50-day SMA
Buy
Level
$48.31
MACD (12, 26)
Buy
Level
1.30
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
164.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.3617)
Sell
CA Score
(Annual)
Level (-0.6562)
Buy
Beneish M-Score
(Annual)
Level (-3.3868)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (0.5004)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
American Healthcare REIT, Inc. operates as a real estate investment trust/REIT. It invests in a diversified portfolio of real estate properties, focusing primarily on medical office buildings, hospitals, skilled nursing facilities, senior housing and other healthcare-related facilities. The company was founded on January 23, 2015 and is headquartered in Irvine, CA.
Stock Forecast FAQ
In the current month, AHR has received 7 Buy ratings 1 Hold ratings, and 0 Sell ratings. The AHR average analyst price target in the past 3 months is $56.08.
-
Where Will American Healthcare REIT, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that American Healthcare REIT, Inc. share price will rise to $56.08 per share over the next 12 months.
-
What Do Analysts Say About American Healthcare REIT, Inc.?
Analysts are divided on their view about American Healthcare REIT, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that American Healthcare REIT, Inc. is a Sell and believe this share price will drop from its current level to $52.00.
-
What Is American Healthcare REIT, Inc.'s Price Target?
The price target for American Healthcare REIT, Inc. over the next 1-year time period is forecast to be $56.08 according to 8 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is AHR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for American Healthcare REIT, Inc. is a Buy. 7 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AHR?
You can purchase shares of American Healthcare REIT, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase American Healthcare REIT, Inc. shares.
-
What Is The American Healthcare REIT, Inc. Share Price Today?
American Healthcare REIT, Inc. was last trading at $51.92 per share. This represents the most recent stock quote for American Healthcare REIT, Inc.. Yesterday, American Healthcare REIT, Inc. closed at $51.93 per share.
-
How To Buy American Healthcare REIT, Inc. Stock Online?
In order to purchase American Healthcare REIT, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get AHR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AHR
Sector
P/E ratio
368.82x
18.50x
PEG ratio
-0.25x
0.05x
P/B ratio
3.45x
0.83x
Price / LTM sales
3.78x
3.22x
Growth Metrics
AHR
Sector
Revenue growth
10.95%
2.37%
Earnings growth
1169.48%
-1.55%
Revenue (5-year growth)
76.54%
3.41%
Earnings forecast
$0.15
$0.13
Profitability
AHR
Sector
Profitability FY 2024
$184.3M
$147.2M
Return on invested capital
0.65%
1.8%
Return on assets
0.6%
1.68%
Return on equity
1.14%
3.34%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
AHR
Sector
Total cash
$184.4M
$70.8M
Short term investments
--
$12.4M
Total assets
$4.5B
$3.2B
Long term debt
$1.7B
$338.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
